Coherus Biosciences | CHRS - Market Capitalization


Coherus Biosciences reported $95.8M in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 444.6B 59.91B Jun/2026
Acadia Pharmaceuticals USD 4.33B 537M Jun/2026
Akebia Therapeutics USD 427M 297M Dec/2025
ALKERMES USD 8.73B 2.85B Jun/2026
Alnylam Pharmaceuticals USD 22.44B 10.57B Oct/2026
Amarin USD 290M 51M Dec/2025
Amgen USD 195.44B 5.55B Jun/2026
Baxter International USD 11.99B 419M Oct/2026
Biogen USD 35.56B 2.19B Oct/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Bristol-Myers Squibb USD 124.51B 2.96B Oct/2026
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 1.31T 216.84B Oct/2026
Gilead Sciences USD 206.51B 21.7B Oct/2026
Merck USD 370.6B 12.1B Oct/2026
Pacira USD 1.69B 694M Oct/2026
Pfizer USD 138.44B 15.37B Jun/2026
PTC Therapeutics USD 4.94B 1.86B Oct/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Teva Pharmaceutical Industries USD 114.54B 80.27B Jun/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026
Xencor USD 1.19B 301M Jun/2026
Zoetis USD 30.13B 19.58B Jun/2026